The Chinese pharmaceutical market is changing drama，The changes in the next ten years are even more sharp and profound。Deep to the original research drug and generic drug market that is deeply enough to affect sales of more than 90%of the patent period，For pharmaceutical companies，The next 3 to 5 years，Challenge is particularly difficult。 This is the conclusion of the Boston Consultation (BCG) after investigating the Chinese market。

 

  On the afternoon of November 23，BCG released its latest report，This report focuses on the strategy of pharmaceutical companies in the Chinese market。The report is "In the changing Chinese market，How does pharmaceutical companies continue to win? 》。This report points out，China's pharmaceutical market is changing major changes，For multinational companies and local companies，In the next 10 years，The original research drug and generic drug market that accounted for 90%of the drug market sales will be reshaped。Although the long -term development direction is clear，But the transition phase of stake sports betting appthe stake betting appnext 3-5 years is full of challenges。

 

  BCG senior partner and managing director、John Wong, Chairman of Greater China, said: & ldquo; for pharmaceutical companies，Understand the impact and timing of future changes，will help them start taking measures to adapt to change，so as to maintain profit level，and maintain or even increase sales and market share at the same time。& rdquo;

 

  Market Great Change

 

  The Chinese pharmaceutical market has always been driven by the demographic dividend and medical reform policy，Of course it also means that the changes in these two factors on the change of the pharmaceutical market are equally huge。With population aging and middle -class、Expansion of the wealthy class，and the government's investment in national medical treatment is increasing，The Chinese pharmaceutical market will continue to expand in the future。

 

  BCG report called，From now to 2020，The average annual compound growth rate of the overall medical expenditure in China will reach 5%-10%。According to the report of the author's expectation，The future pharmaceutical market will gradually gradually from the current hospital -centered system，Stepping to turn more & ldquo; decentralization & rdquo; mode，Including three main sales channels: Hospital、Grassroots medical institutions and retail pharmacies。

 

  Survey results show，At present, the hospital occupies 80%of the drug sales，In the next ten years, it will still be the largest drug sales market，But its market share will drop sharply。Report predict 2021，Due to the implementation of the government's implementation of drug sales & ldquo; zero price increase & rdquo; policy，At the same time, the stricter drug ratio control，Hospital's drug sales share will decrease 5%-8%。Since then，Drug sales from hospitals to grassroots medical institutions、The speed of retail pharmacy will accelerate，By 2026, the proportion of hospitals in drug sales will drop to 50%-60%。

 

  stake betting appIn the stake betting appprocess of decentralization & rdquo;，The commercialization model in the hospital will also develop from a model -dominated model to market access -dominated model。More severe bidding policy，Drugs who pass the quality consistency will be at the same level of quality as the original drugs，and the continuous expanded medical consortium and GPO -led secondary bargaining will continue to lower the drug price，Reduce product profits， But it will also reduce the number of supply manufacturers，Link the discounts of drugs to procurement，Re -reshuffle of pharmaceutical companies。

 

  According to report author forecast，By 2026，Drug sales of grass -roots medical institutions will be almost doubled，About 16%of the total market，The specific proportion depends on the outlook of hospital -based prospects and the prospects of the balanced structure.。Grass -roots medical institutions will get a license，Extended Drug Supply Catalog，At the same time, grassroots medical institutions will have more sufficient general doctors，Attract more patients with chronic diseases at the grassroots medical institutions for treatment and prescribing medicine，These will bring sales growth。Looking at it for a long time，grass -roots medical institutions will become patients with chronic diseases for treatment、Prescription、The main channel of the pill，But the economically effective coverage of this channel will be full of challenges。

 

  Although the hospital system challenge，But retail is constantly emerging more opportunities。Current，Retail pharmacy is just a relatively small sales channel for prescription drugs，From the long term，It has the greatest growth opportunity。In the next 10 years，In the prospect of hospital -based，Pharmaceuticals will increase from the current 11%to 25%，In the prospect of the balanced structure，The above ratio will increase to nearly 35%。The speed and amplitude stake betting appstake online sports bettingof the transfer from the hospital to the pharmacy，Depending on the hospital's can quickly increase medical service costs，and when can the introduction of and comprehensively develop market -oriented drug cost control mechanisms in retail channels。Another，The government also needs to provide policy support and incentives through pharmacies with drug distribution，Accelerate the transfer of medicine from the hospital to a pharmacy。

 

  How to deal with pharmaceutical companies

 

  bcg thinks，Pharmaceutical companies can be based on short、、Long -term change roadmap，Segment the target market，and perform priority sort。Although the situation of each enterprise is different，But in general, most companies can develop strategies and methods according to channels。

 

  On the channels of hospitals and large grassroots medical institutions，Although the price and profit are facing pressure and challenge，Enterprises still need to give the highest priority to this channel。In the next three to five years，Enterprises need to be based on market potential and policy maturity，Select key provinces，Optimize and strengthen access resources and capabilities at the provincial level，and adjust the sales mode，Continue to promote sales、Improve sales efficiency，to offset the impact of the decreased drug price。

 

  On the channels of other grass -roots medical institutions，For most enterprises，Due to continuous changes in market conditions、Small volume of primary medical institutions、Diversified regional distribution，Although the future growth prospects are very good，The priority of this channel is still low。

 

  In the retail pharmacy section，This channel will become a engine of growth for a long time，Especially for those who can develop big customers' management capabilities、Pharmaceutical companies that formulate and adopt effective terminal management measures。

 

  Stake Sports Bettingstake online sports bettingBCG partner and managing director Chen Baiping said: & ldquo; for pharmaceutical companies，China will still be a high -speed growth market。But at the same time we can clearly see，The market is constantly changing，In the next three to five years，The change will be even more intense。If you want to seize the opportunity of growth，Pharmaceutical companies need to rethink and adjust their strategy、Skills and organizational structure，so as to be able to adapt to the evolution of the market。Most pharmaceutical companies have to change，But those fast -moving companies will win significant competitive advantages。& rdquo;